Examining the Relationship between Discrimination and Prescription Drug Misuse: Findings from a National Survey of Black Americans

Subst Use Misuse. 2022;57(7):1014-1021. doi: 10.1080/10826084.2022.2052096. Epub 2022 Apr 8.

Abstract

Background: Research shows that substance use may be a way individuals cope with psychosocial stressors. Less is known about whether discrimination contributes to prescription drug misuse. Methods: Using a national sample of Black Americans, we examined whether two psychosocial stressors (i.e., everyday and lifetime major discrimination) were associated with lifetime prescription drug misuse (i.e., opioids, tranquilizers, sedatives, or stimulants). Results: Our logistic regression models separately examining the influence of everyday and major discrimination controlling for relevant demographic, health, and other drug use variables showed that only everyday discrimination was associated with higher odds of prescription drug misuse. In the model simultaneously considering both types of discrimination, only unit increases in everyday discrimination were associated with higher odds of prescription drug misuse. Conclusions: Encounters with everyday discrimination may be an important psychosocial stressor linked to prescription drug misuse in Black adults and possibly other racial-ethnic minorities. Intervention strategies aiming to reduce prescription drug misuse should consider developing ways to curb the negative health-related consequences of discriminatory experiences. Strategies to combat discrimination-related prescription drug misuse and limitations of this study are discussed.

Keywords: Black American; Discrimination; coping responses; prescription drug misuse; stress; substance use.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Analgesics, Opioid
  • Black or African American
  • Central Nervous System Stimulants*
  • Ethnicity
  • Humans
  • Prescription Drug Misuse*
  • Substance-Related Disorders* / psychology

Substances

  • Analgesics, Opioid
  • Central Nervous System Stimulants